The Clinical Response of Choline Acetyltransferase and Apolipoprotein Epsilon Gene Polymorphisms to Donepezil in Alzheimer's Disease
NCT00381381
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
199
Enrollment
INDUSTRY
Sponsor class
Conditions
Alzheimer's Disease
Interventions
DRUG:
Donepezil
Sponsor
Eisai Korea Inc.